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Abstract
Background: Vaccine coverage (VC) at a given age is a widely-used indicator for measuring the performance of
vaccination programs. However, there is increasing data suggesting that measuring delays in administering
vaccines complements the measure of VC. Providing feedback to vaccinators is recognized as an effective strategy
for improving vaccine coverage, but its implementation has not been widely documented in Canada. The
objective of this study was to evaluate the feasibility of providing personalized feedback to vaccinators and its
impact on vaccination delays (VD).
Methods: In April and May 2008, a one-hour personalized feedback session was provided to health professionals in
vaccinating medical clinics in the Quebec City region. VD for vaccines administered at two and twelve months of
age were presented. Data from the regional vaccination registry were analysed for participating clinics. Two
12-month periods before and after the intervention were compared, namely from April 1
st, 2007 to March 31
st,
2008 and from June 1
st, 2008 to May 31
st, 2009.
Results: Ten medical clinics out of the twelve approached (83%), representing more than 2500 vaccinated children,
participated in the project. Preparing and conducting the feedback involved 20 hours of work and expenses of
$1000 per clinic. Based on a delay of one month, 94% of first doses of DTaP-Polio-Hib and 77% of meningococcal
vaccine doses respected the vaccination schedule both before and after the intervention. Following the feedback,
respect of the vaccination schedule increased for vaccines planned at 12 months for the four clinics that had
modified their vaccination practices related to multiple injections (depending on the clinic, VD decreased by 24.4%,
32.0%, 40.2% and 44.6% respectively, p < 0.001 for all comparisons).
Conclusions: The present study shows that it is feasible to provide personalized feedback to vaccinating clinics.
While it may have encouraged positive changes in practice concerning multiple injections, this intervention on its
own did not impact vaccination delays of the clinics visited. It is possible that feedback integrated into other types
of effective interventions and sustained over time may have more impact on VD.
Background
Child vaccination is one of the most effective interven-
tions in public health [1,2]. Vaccine coverage (VC) at a
given age is a widely-used indicator for measuring the
performance of vaccination programs [3]. However,
there is increasing data suggesting that measuring
delays in age-appropriate vaccination complements the
measure of VC [4-6]. Vaccination delays (VD) can, inde-
pendently of VC, increase the burden of certain child-
hood diseases such as pertussis and measles [7,8].
Moreover, a delay in the administration of vaccines
scheduled for the age of two months is associated with
poor VC at two years [3,9,10].
Across Canada, a consensus has been reached on the
definition of VD, namely one month after the due date
on the vaccination schedule [11]. This definition is in
line with the principal studies on the subject [4,6,12-15].
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and Social Services has compiled VD noted in Health
and Social Service Centres (Centres de santé et de ser-
vices sociaux or CSSS) based on a delay of one week fol-
lowing the recommended age [16]. This tracking of VD
is not carried out in private medical clinics, which
administer about half of the vaccines for infants in the
province of Quebec [3,17].
In 2008, in Quebec, using a one-month delay defini-
tion, only 21% of children received all the vaccines
scheduled before the age of two years within the recom-
mended period [3].
Providing feedback to vaccinators is one of the effec-
tive strategies for improving VC [18-24]. It involves pre-
senting clinicians with their performance data, with or
without recommendations [25]. This intervention is car-
ried out following data collection on clinicians’ perfor-
mance (audit). Certain studies have shown that feedback
may help reduce VD and missed vaccination opportu-
nities [18,26]. On the other hand, the impact and feasi-
bility of providing feedback to vaccinating medical
clinics have not been documented extensively in a
Canadian context [27,28].
The main objective of this study was to evaluate the
feasibility and the impact on VD of providing persona-
lized feedback to medical clinics that vaccinate infants
in the Quebec City region.
Methods
Participants
The twelve medical clinics that had administered the
largest number of doses of DTaP-Polio-Hib vaccine in
2007 in the Quebec City region were approached to par-
ticipate in the feedback project. The vaccination registry
(VAXIN), which compiles all doses administered in the
Quebec City region, enabled to identify these clinics and
to evaluate vaccination delays.
Intervention
In April and May 2008, a one-hour feedback session, led
by a physician and a public health nurse, was carried out
with the physicians, nurses and secretaries in each parti-
cipating medical clinic. This feedback dealt with VD for
infants at the clinic for the year 2007. Data on the pro-
portion of doses administered without delay were
presented for the first doses of three vaccines (DTaP-
Polio-Hib, pneumococcal and meningococcal). Vaccina-
tion delays for each clinic were presented both in terms
of the Quebec standard (one week) and the proposed
Canadian standard (one month). Graphs showing the
cumulative percentage of children vaccinated according
to age were also presented for vaccines scheduled at 2
and 12 months, including measles, mumps and rubella
vaccine (MMR). During preparation of the feedback, it
became clear that certain clinics were not administering
vaccines scheduled at one year during a single visit.
Consequently, information on the importance of multi-
ple injections was transmitted to these medical clinics.
Ethical approval was obtained from the Comité d’éthique
d el ar e c h e r c h ed uC H U Q-C e n t r eh o s p i t a l i e rd el ’Uni-
versité Laval (project C10-11-101).
Questionnaire
At the end of each feedback session, a questionnaire on
the organizational characteristics of the clinic in terms
of vaccination was completed on site by a nurse or a
secretary. One year following the feedback session (July
2009), the same questionnaire was completed by tele-
phone and, when possible, with the same person.
Feasibility
The data related to the feasibility of the intervention,
i.e., the material, human and financial resources
required, were compiled.
Analyses of vaccination delays
In order to measure the impact of the feedback on
delays associated with vaccines (1
st dose of DTaP-Polio-
Hib, 1
st dose of pneumococcal, meningococcal and 1
st
dose of MMR), data from the regional vaccination regis-
try were analyzed for the participating clinics. Two
12-month periods before and after the intervention were
compared, namely from April 1
st, 2007 to March 31
st,
2008 and from June 1
st, 2008 to May 31
st, 2009. Two
indicators of delay were considered: one week and one
month after the due date on the vaccination schedule.
Proportion comparisons were carried out using the chi-
square test. The distributions of ages at vaccination,
before and after the intervention, were compared using
the Wilcoxon test. The analyses were carried out using
the SAS 9.1 software (SAS Institute, Cary, NC).
Results
Participation
A total of ten clinics (83%), representing more than
2500 vaccinated children, agreed to participate in the
feedback project. Out of the 206 physicians, nurses and
secretaries working in these ten clinics, 106 participated
in the feedback process (51%).
Organizational characteristics of the medical clinics
Table 1 summarizes the organizational characteristics of
the clinics visited and the changes observed between the
ends of each of the two observation periods. Among
other characteristics, it was noted that four clinics chan-
ged their practices concerning multiple injections. For
two of these four clinics, responsibilities concerning
vaccination were given to nurses. Since 2002, in the
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Page 2 of 8province of Quebec, nurses have the possibility to vacci-
nate as set out in the Public Health Act [29].
Vaccination delays
During the second observation period, 94% of the first
doses of DTaP-Polio-Hib and pneumococcal vaccines
were received within the one-month delay (Table 2).
This proportion was 77% for meningococcal vaccine and
75% for MMR (Table 3). When a delay of one week
after the scheduled vaccination date was applied, the
proportion of doses received without delay was 56% for
DTaP-Polio-Hib and pneumococcal vaccines, 34% for
meningococcal vaccine and 33% for MMR.
Few changes were observed before and after the feed-
back (Tables 2 and 3). Using the one-month delay, no
statistically significant difference in VD was found
between the two periods. Using the one-week delay, a
statistically significant increase in VD was observed for
DTaP-Polio-Hib (8.9%, p < 0.001), pneumococcal (9.0%,
p < 0.001) and meningococcal (2.7%, p = 0.036) vaccines.
The median age at vaccination increased in a statisti-
cally significant manner for DTaP-Polio-Hib and pneu-
mococcal vaccines (+ 2 days, p < 0.0001). For all
vaccines, the difference in median age at vaccination
before and after the feedback was nevertheless very
small, consistently less than 3 days (Table 4).
As can be seen in Figure 1, age at vaccination for
DTaP-Polio-Hib and meningococcal vaccines for the
2008-2009 period was comparable to that for the 2007-
2008 period, with both curves being superimposed.
For the four clinics that began the practice of multiple
injections in 2008-2009, a significant decrease in VD
was observed for vaccines scheduled at 12 months. For
the third dose of the pneumococcal vaccine (given at 12
months), the proportion of infants immunized within a
one-month delay increased from 19.6% to 51.6% (p <
0,001) for clinic 10 and from 29.3% to 73.9% (p < 0,001)
for clinic 09. The proportion of infants immunized with-
o u td e l a yf o rt h ef i r s td o s eo fM M Ri n c r e a s e df r o m
27.4% to 67.6% (p < 0,001) for clinic 05. Finally, the
Table 1 Characteristics of clinics at the end of the second observation period and changes observed
Clinic Organizational characteristics (X = yes)
If delay noted:
Child seen very
rapidly
(otherwise, child
referred)
Possibility of
vaccinating a child
without
appointment
Possibility of
extending
clinic hours
Possibility of
making an
appointment with a
nurse only
Multiple
injections at
12 months
encouraged
Possibility of
making an
appointment on
site
Telephone
reminder
before an
appointment
01 XX
02 XX
03 XX X X
04 XX X X X
05 XX X X
a, c X
b XX
06 XX X X
c X
b X
07 X
08 X X
09 X
b XX
10 XX X
b X
a During the second observation period, hiring of two nurses who vaccinate on an appointment basis.
b Unlike the end of the first observation period, multiple injections are now encouraged.
c During the second observation period, nurses began vaccinating children at 12 months on an appointment basis.
Table 2 Doses of vaccines administered without delay before and after feedback for the 10 clinics
Vaccines planned at 2 months of age and indicator Proportion without delay
Before feedback (2007-2008)
Proportion without delay
After feedback (2008-2009)
Difference p
1
st DTaP-Polio-Hib Doses = 3297 Doses = 3519
1 week 64.8% 55.9% - 8.9% < 0.001
1 month 93.6% 93.6% 0.0% 0.970
1
st Pneumococcal Doses = 3272 Doses = 3504
1 week 65.0% 56.0% - 9.0% < 0.001
1 month 94.0% 93.8% - 0.3% 0.656
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meningococcal vaccine increased from 56.5% to 80.9%
(p < 0,001) for clinic 06. Figure 2 (a and b) illustrates
this situation for two of the four clinics.
Feasibility
The preparation and completion of the feedback ses-
sions required, in terms of human resources, the contri-
bution of a physician (42 hours), two nurses (48 hours),
a statistician (42 hours) and a research officer (74
hours). The cost of preparing and carrying out the
meetings in the ten clinics (professional hours, materi-
als, travel and cold meals served) was estimated at
$10,000.
Discussion
The feedback process conducted in 10 of the 12 main
vaccinating clinics in the Quebec City region did not
decrease overall vaccination delays. A high proportion of
the DTaP-Polio-Hib and pneumococcal vaccines were
administered before the age of three months (94%), both
before and after the intervention. The proportion of
doses administered without delay was lower for menin-
gococcal (77%) and MMR (73-75%) vaccines.
Vaccination delays observed in this study are similar
or compare favourably with VD documented in other
countries for MMR [13,14] or for vaccines containing
certain elements of DTaP-Polio-Hib [30,31]. Neverthe-
less caution must be exercised in comparing VD data
given the different methodologies employed.
Several reasons could explain the low impact of the
intervention conducted herein. Firstly, this was an iso-
lated intervention not combined with other types of
interventional activities. Feedback that is integrated into
other activities and sustained over time, such as that
inspired by the Assessment, Feedback, Incentives and
Exchange (AFIX) strategy, appears to be more likely to
have an impact on vaccination [20,23,32]. Moreover, an
increase in the number of doses administered in 2008-
2009 was noted compared to 2007-2008. The pressure
represented by this increased demand for vaccination
could have contributed to the low impact of the feed-
back. As well, only half of the health professionals
involved in vaccination in the clinics that were visited
participated in the feedback process. The impact ana-
lyses, on the other hand, dealt with the totality of vacci-
nation acts in the participating clinics, since the registry
does not include a specific code for each vaccinator.
Finally, VD presented were relatively low for some
clinics and may not have generated sufficient motivation
to change current practices. However, the feedback pro-
vided could have influenced more specific problematic
practices resulting in high VD.
It is possible that the feedback was the cause of the
decrease in VD observed for the four clinics that modi-
fied their practices concerning multiple injections. It is
also possible that the introduction of the combined
measles, mumps, rubella and varicella vaccine (MMR-V)
administered at one year of age as well as the involve-
ment of nurses in vaccination contributed to these
Table 3 Doses of vaccines administered without delay before and after feedback for the 10 clinics
Vaccines planned at 12 months of
age and indicator
Proportion without delay Before
feedback (2007-2008)
Proportion without delay After
feedback (2008-2009)
Difference p
Meningococcal Doses = 2787 Doses = 2870
1 week 36.9% 34.2% - 2.7% 0.036
1 month 77.0% 77.0% + 0.0% 0.973
1
st MMR Doses = 2858 Doses = 2941
1 week 33.9% 33.2% - 0.8% 0.525
1 month 72.7% 74.9% + 2.2% 0.053
Table 4 Median age at vaccination before and after feedback for the 10 clinics
Before feedback (2007-2008) After feedback (2008-2009)
Vaccine Doses
administered
Median age
(months)
Doses administered Median age
(months)
Difference
(days)
p
1
st DTaP-Polio-Hib 3297 2.14 3519 2.20 + 2 < 0.0001
1
st Pneumococcal 3272 2.14 3504 2.20 + 2 < 0.0001
Meningococcal 2787 12.39 2870 12.42 + 1 0.07
1
st MMR 2858 12.45 2941 12.45 0 0.65
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Page 4 of 8changes. Two of the four clinics involved hired nurses
or gave nurses additional responsibilities following the
feedback. Other studies suggest that the involvement of
nurses favours adherence to recommendations regarding
vaccination [17]. These results are important, since the
practice of multiple injections is a factor that facilitates
complete immunization [33]. However, these modifica-
tions did not appear to have an impact on global
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Figure 1 Cumulative percentage of children vaccinated in the 10 clinics before and after the feedback intervention.
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Page 5 of 8analyses. A possible hypothesis is that the decrease in
VD was observed in four of the smallest clinics that
only gave a limited number of vaccine doses, therefore
having a limited weight compared to larger clinics.
A relatively wide consensus exists concerning the defi-
nition of VD, namely one month after the date on the
immunization schedule [34]. In the present study, the
results using this standard did not suggest any deteriora-
tion or improvement in VD after feedback. When using
a one-week standard, we observed an increase in VD for
the first DTaP-Polio-Hib vaccine, for the first pneumo-
coccal vaccine and for the meningococcal vaccine. How-
ever, these increases in VD correspond to a mean
immunization time delayed by only one or two days in
the year following the feedback, a difference not clini-
cally significant. It is possible that using a one-week
definition for VD may be too sensitive to very minor
changes in immunization practices and lead to misinter-
pretations. Furthermore, using a short one-week stan-
dard for VD could demoralize clinicians because it is
very difficult to reach. This issue was reported by some
participants during the feedback sessions.
In Quebec, the Ministry of Health and Social Services
tracks the vaccination delays associated with DTaP-
Polio-Hib, pneumococcal and meningococcal vaccines.
Strict surveillance of VD for DTaP-Polio-Hib vaccine is
essential, as delays in its administration are associated
with incomplete VC [3]. Since the VD for pneumococcal
vaccine are almost identical to that for DTaP-Polio-Hib,
and since it is scheduled for the same visit, the benefits
associated with its surveillance appear rather limited.
A number of limitations of this study should be men-
tioned. A high proportion of vaccination acts are recorded
in the vaccination registry used (VAXIN) [35]. However,
when children move to the Quebec City region, it is possi-
ble that vaccines given previously in other regions may not
be systematically reported and recorded. This phenom-
enon is apt to lead to an overestimation of VD, but should
be consistent over time. The fact that the VD determined
by this study are close to the data reported in provincial
studies is nevertheless reassuring [3].
The questionnaire was completed in person after the
first observation period and by telephone after the sec-
ond observation period. As well, the same person was
reached in only five of the ten clinics. An effort was
made to limit the impact of this latter factor by formu-
lating the questions in the same manner.
Finally, the use of a control group would have allowed
for the impact of the feedback to be better identified.
However, such a strategy would have been extremely
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Figure 2 Cumulative percentage of children vaccinated before (A) and after (B) feedback for two clinics.
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Page 6 of 8difficult to apply since a large majority of doses are
administered by a small number of clinics in the Quebec
City region and the clinics that vaccinate the most were
the ones that participated in the study. Nevertheless, we
compared the VD observed during the two periods for
those clinics that did not participate in the project and
the same tendencies were noted.
Conclusions
While the feedback that was provided did not lead to a
decrease in VD, it nevertheless appeared to have facili-
tated certain positive changes in practices concerning
multiple injections. It is possible that feedback inte-
grated into other types of effective interventions, sus-
tained over time or giving certain responsibilities to
vaccinators may have more impact in decreasing VD.
These measures, however, would require additional
resources. Efforts aimed at reducing the burden related
to delayed immunization and at improving VC should
be pursued in order to protect the population against
diseases that can be avoided by vaccination.
Abbreviations
DTaP-Polio-Hib: Diphtheria, tetanus toxoid, acellular pertussis, inactivated
poliovirus and Haemophilus influenzae type b vaccine; MMR: Measles, mumps
and rubella vaccine; MMR-V: Measles, mumps, rubella and varicella vaccine;
VC: Vaccine coverage; VD: Vaccination delays.
Acknowledgements
The authors would like to thank Ève Dubé, Geneviève Tremblay and Nicole
Boulianne for their judicious comments on previous versions of this article.
We would also like to thank Josiane Rivard for her technical support and
Marie-France Richard for the layout of the manuscript. Finally, we would like
to thank the company Wyeth for its financial support in the context of its
Partnering for Protection program as well as the participating clinics, without
whom this study could not have taken place. The funding body was not
involved in any part of the study.
Author details
1Institut national de santé publique du Québec, Québec, Canada.
2Centre de
recherche du CHUL-CHUQ, Centre Hospitalier Universitaire de Québec,
Québec, Canada.
3Direction régionale de santé publique de la Capitale-
Nationale, Québec, Canada.
4Université Laval, Québec, Canada.
Authors’ contributions
NB participated for the data collection and wrote the first draft of the
manuscript. CS conceived the study, coordinated the data collection, carried
out the feedback intervention, and helped in drafting the manuscript. MO
and GD performed the statistical analysis and helped in drafting the
manuscript. MK participated in data collection and helped in writing the first
draft of the manuscript. DA, AP and CC prepared and conducted the
feedback sessions for medical clinics, participated in data collection and
helped in the writing of the manuscript. All authors read and approved the
final manuscript.
Competing interests
Competing interests for CS: research grants, honoraria and reimbursement of
travel costs by the following companies: Wyeth, GlaxoSmithKline and Merck
Frost. The other authors declare that they have no competing interest.
Received: 29 May 2010 Accepted: 3 December 2010
Published: 3 December 2010
References
1. Bos E, Batson A: Using immunization coverage rates for monitoring
health sector performance: Measurement and interpretation issues.
Washington DC: Human development network, The World Bank; 2000, 1-21.
2. Comité consultatif national sur l’immunisation (Ed.): Guide canadien
d’immunisation. 7 edition. Ottawa: Agence de la santé publique du Canada;
2006, 410.
3. Boulianne N, Bradet R, Audet D, Deceuninck G: Enquête sur la couverture
vaccinale des enfants de 1 an et 2 ans au Québec en 2008. Québec:
Institut national de santé publique du Québec; 2009, 1-205.
4. Dombrowski KJ, Lantz PM, Freed GL: The need for surveillance of delay in
age-appropriate immunization. Am J Prev Med 2002, 23(1):36-42.
5. Luman ET, McCauley MM, Stokley S, Chu SY, Pickering LK: Timeliness of
childhood immunizations. Pediatrics 2002, 110(5):935-939.
6. Akmatov MK, Kretzschmar M, Kramer A, Mikolajczyk RT: Timeliness of
vaccination and its effects on fraction of vaccinated population. Vaccine
2008, 26(31):3805-3811.
7. Shinall MC Jr, Peters TR, Zhu Y, Chen Q, Poehling KA: Potential impact of
acceleration of the pertussis vaccine primary series for infants. Pediatrics
2008, 122(5):1021-1026.
8. The National Vaccine Advisory Committee: The measles epidemic. The
problems, barriers, and recommendations. JAMA 1991, 266(11):1547-1552.
9. Dietz VJ, Stevenson J, Zell ER, Cochi S, Hadler S, Eddins D: Potential impact
on vaccination coverage levels by administering vaccines
simultaneously and reducing dropout rates. Arch Pediatr Adolesc Med
1994, 148(9):943-948.
10. Wood D, Pereyra M, Halfon N, Hamlin J, Grabowsky M: Vaccination levels
in Los Angeles public health centers: The contribution of missed
opportunities to vaccinate and other factors. Am J Public Health 1995,
85(6):850-853.
11. Canadian Immunization Registry network Task Group, Boulianne N,
Hemon Y-A, Mawhinney T, Strong D, Gemmill I, Dobson S, Sartison E,
Sargent M, Naus M, Tuchscherer R, Craig E, Watkins K, Schouten H: National
eligible, due and overdue guidelines for immunization registries: draft
recommendations from the Canadian Immunization Registry Network,
Data Standards Task Group. Can Commun Dis Rep 2004, 30(6):53-59.
12. Luman ET, Barker LE, Shaw KM, McCauley MM, Buehler JW, Pickering LK:
Timeliness of childhood vaccinations in the United States: days
undervaccinated and number of vaccines delayed. JAMA 2005,
293(10):1204-1211.
13. Hull BP, McIntyre PB: Timeliness of childhood immunisation in Australia.
Vaccine 2006, 24(20):4403-4408.
14. Dayan GH, Shaw KM, Baughman AL, Orellana LC, Forlenza R, Ellis A, Chaui J,
Kaplan S, Strebel P: Assessment of delay in age-appropriate vaccination
using survival analysis. Am J Epidemiol 2006, 163(6):561-570.
15. Grant CC, Roberts M, Scragg R, Stewart J, Lennon D, Kivell D, Ford R,
Menzies R: Delayed immunisation and risk of pertussis in infants:
unmatched case-control study. BMJ 2003, 326(7394):852-853.
16. Ministère de la Santé et des Services sociaux: Ententes de gestion, fiche
descriptive des indicateurs - Fiche 1.1 FGJ. 2006.
17. Sauvageau C, Trépanier J-P, Guay M, Landry M, Ben-Yedder N, Laflamme M,
Minh Man Nguyen M, Weil A, Hudson P, Royer L, Ouakki M, Pelletier A,
Boulianne N: Vaccination en clinique médicale: y a-t-il des délais? Montréal.
Journées annuelles de santé publique; 2006, 23-27.
18. LeBaron CW, Chaney M, Baughman AL, Dini EF, Maes E, Dietz V, Bernier R:
Impact of measurement and feedback on vaccination coverage in public
clinics, 1988-1994. JAMA 1997, 277(8):631-635.
19. Briss PA, Rodewald LE, Hinman AR, Shefer AM, Strikas RA, Bernier RR,
Carande-Kulis VG, Yusuf HR, Ndiaye SM, Williams SM: Reviews of evidence
regarding interventions to improve vaccination coverage in children,
adolescents, and adults. Am J Prev Med 2000, 18(1S):97-140.
20. LeBaron CW, Mercer JT, Massoudi MS, Dini E, Stevenson J, Fischer WM,
Loy H, Quick LS, Warming JC, Tormey P, DesVignes-Kendrick M: Changes in
clinic vaccination coverage after institution of measurement and
feedback in 4 states and 2 cities. Arch Pediatr Adolesc Med 1999,
153(8):879-886.
21. Bordley WC, Chelminski A, Margolis PA, Kraus R, Szilagyi PG, Vann JJ: The
effect of audit and feedback on immunization delivery: a systematic
review. Am J Prev Med 2000, 18(4):343-350.
Brousseau et al. BMC Public Health 2010, 10:750
http://www.biomedcentral.com/1471-2458/10/750
Page 7 of 822. Fairbrother G, Hanson KL, Friedman S, Butts GC: The impact of physician
bonuses, enhanced fees, and feedback on childhood immunization
coverage rates. Am J Public Health 1999, 89(2):171-175.
23. Melinkovich P, Hammer A, Staudenmaier A, Berg M: Improving pediatric
immunization rates in a safety-net delivery system. Jt Comm J Qual
Patient Saf 2007, 33(4):205-210.
24. Zara S, Briss PA, Harris KW: In The Guide to Community Preventive Services -
What Works to Promote Health? Edited by: Stephanie Zaza, Peter A Briss
2005, 544.
25. Oxman AD, Thomson MA, Davis DA, Haynes RB: No magic bullets: a
systematic review of 102 trials of interventions to improve professional
practice. CMAJ 1995, 153(10):1423-1431.
26. Sabnis SS, Pomeranz AJ, Amateau MM: The effect of education, feedback,
and provider prompts on the rate of missed vaccine opportunities in a
community health center. Clin Pediatr (Phila) 2003, 42(2):147-151.
27. Lemelin J, Hogg W, Baskerville N: Evidence to action: a tailored
multifaceted approach to changing family physician practice patterns
and improving preventive care. CMAJ 2001, 164(6):757-763.
28. Borgiel AE, Williams JI, Davis DA, Dunn EV, Hobbs N, Hutchison B,
Wilson CR, Jensen J, O’Neil JJ, Bass MJ: Evaluating the effectiveness of 2
educational interventions in family practice. CMAJ 1999, 161(8):965-970.
29. Assemblée nationale: Projet de loi no 90 - Loi modifiant le Code des
professions et d’autres dispositions législatives dans le domaine de la
santé. Éditeur officiel du Québec; 2002, 1-20.
30. Kalies H, Grote V, Schmitt HJ, von Kries R: Immunisation status of children
in Germany: temporal trends and regional differences. Eur J Pediatr 2006,
165(1):30-36.
31. Estimated Vaccination Coverage with Individual Vaccines by 3 Months
of Age by State and Local Area US, National Immunization Survey, 2008
(consulted on October 26, 2009). 2008 [http://www.cdc.gov/vaccines/
stats-surv/nis/tables/08/tab04_3mo_iap.xls].
32. Massoudi MS, Walsh J, Stokley S, Rosenthal J, Stevenson J, Miljanovic B,
Mann J, Dini E: Assessing immunization performance of private
practitioners in Maine: impact of the assessment, feedback, incentives,
and exchange strategy. Pediatrics 1999, 103(6 Pt 1):1218-1223.
33. Boulianne N, Deceuninck G, Duval B: Pourquoi certains enfants sont
incomplètement vaccinés à l’âge de 2 ans? Rev can santé publ 2003,
94(3):218-223.
34. Dietz VJ, Zell ER, Stevenson J: Defining delayed immunization. Pediatr
Infect Dis J 1993, 12(4):353-354.
35. Guay M, Boulianne N, Ménard S, Clouâtre A-M, Clément P, Tremblay A,
Blackburn M, Lemaire J, Douville-Fradet M: Étude de validation et
d’appréciation des fichiers de vaccination et de population en Estrie, en
Montérégie et dans la région de Québec. Québec: Centre de recherche
Hôpital Charles LeMoyne; 2005, 1-70.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2458/10/750/prepub
doi:10.1186/1471-2458-10-750
Cite this article as: Brousseau et al.: Feasibility and impact of providing
feedback to vaccinating medical clinics: evaluating a public health
intervention. BMC Public Health 2010 10:750.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Brousseau et al. BMC Public Health 2010, 10:750
http://www.biomedcentral.com/1471-2458/10/750
Page 8 of 8